The role of SREBP1c in the pathogenesis of NAFLD is further supported by mouse studies where the transcriptionally active form of SREBP1c is expressed in a liver‐specific manner and leads to a consequent accumulation of hepatic lipid droplets (Knebel et al., 2012). This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.